Skip to main content

Table 1 Clinical characteristics of patients (N = 22)

From: Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma

Characteristics

N (%)

Sex

 Female

8 (36.4)

 Male

14 (63.6)

Age

  > 65

11 (50.0)

  ≤ 65

11 (50.0)

Pathological response

 IPR

5 (22.7)

 MPR

6 (27.3)

 pCR

7 (31.8)

 Unknown

4 (18.2)

Smoking history

 Never smokers

14 (63.6)

 Former/current smokers

7 (31.8)

 Unknown

1 (4.55)

Clinical stage

 II

10 (45.5)

 III

11 (50.0)

 IV

1 (4.55)

Histological subtype

 ESCC

21 (95.5)

 EASC

1 (4.55)

TPS

    < 1%

15 (68.2)

 1% ≤ TPS < 50%

1 (4.5)

  ≥ 50%

4 (18.2)

 Unknown

2 (9.1)

CPS

  < 1

10 (45.5)

 1 ≤ TPS < 10

3 (13.6)

 10 ≤ TPS < 50

3 (13.6)

  ≥ 50

4 (18.2)

 Unknown

2 (9.1)

  1. IPR incomplete pathological response, MPR major pathological response, pCR pathological complete response, ESCC esophageal squamous cell carcinoma, EASC esophageal adenosquamous carcinoma, TPS tumor proportion score, CPS combined positive score